IPCALABBSEIPCA LABORATORIES LTDHighNeutral
Announced Tue, 14 Jul · 10:11 IST

Annual Report FY26 - PAT up 74%, revenue up 10%, dividend raised to 600%

Pat Growth 25pctEbitda Margin ExpansionResults View source PDF

IPCALAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.2%1-day move
₹1824.90
prior close
₹1839.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1-0.6-0.7-0.5+2.2+3.2+6.3+0.3-1.6-2.9
Up moveDown movePending
AI summary

Ipca Labs posted FY26 standalone total income of Rs 7,431 crore, up 10% from Rs 6,749 crore. Net profit jumped 74% to Rs 1,132.5 crore from Rs 650.8 crore. EBITDA rose 22.5% to Rs 1,942 crore with margins improving to 26.1% from 23.5%. EPS climbed to Rs 44.64 from Rs 25.65. Dividend raised to 600% from 400%. 76th AGM scheduled for 13 August 2026.

Likely market impact

Strong earnings with 74% PAT growth, margin expansion, and higher dividend signal robust momentum for shareholders.